Condensed Consolidated Interim Statements of Cash Flows - USD ($)
|
1 Months Ended |
3 Months Ended |
12 Months Ended |
Apr. 21, 2016 |
Jun. 30, 2018 |
Jun. 30, 2017 |
Mar. 31, 2018 |
Mar. 31, 2017 |
| Operating activities |
|
|
|
|
|
| Net loss for the period |
|
$ (760,698)
|
$ (2,240,518)
|
$ (14,625,790)
|
$ (8,069,402)
|
| Adjustment for items not affecting cash |
|
|
|
|
|
| Depreciation |
|
17,595
|
24,552
|
89,026
|
79,868
|
| Amortization |
|
71,053
|
92,949
|
323,905
|
550,080
|
| Interest expense |
|
36,702
|
72,766
|
1,294,005
|
41,934
|
| Share based compensation expense |
|
595,412
|
251,048
|
1,540,580
|
844,162
|
| Accretion expense |
|
134,251
|
0
|
1,937,308
|
0
|
| Fair value adjustment |
|
44,087
|
0
|
|
|
| Shares issued for services |
|
|
|
0
|
157,788
|
| Share premium |
|
|
|
1,249,994
|
0
|
| (Gain) loss on market to market revaluation |
|
(2,048,697)
|
0
|
376,674
|
0
|
| Allowance for doubtful accounts |
|
(19,694)
|
0
|
(19,694)
|
0
|
| Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities |
|
(1,929,989)
|
(1,799,203)
|
(7,833,992)
|
(6,395,570)
|
| Changes in non-cash working capital items |
|
|
|
|
|
| Accounts receivable |
|
(137,756)
|
248,977
|
190,867
|
(377,413)
|
| Prepaid expenses and other receivables |
|
(51,783)
|
55,996
|
(205,608)
|
20,525
|
| Due from related parties |
|
350
|
(635)
|
(166)
|
22,714
|
| Inventories |
|
81,648
|
(27,297)
|
(9,194)
|
(39,370)
|
| Accounts payable |
|
11,468
|
104,648
|
(60,098)
|
(375,572)
|
| Accrued liabilities |
|
(402,141)
|
(5,428)
|
304,048
|
18,674
|
| Customer advances |
|
0
|
108,300
|
(120,762)
|
35,075
|
| Deferred revenue |
|
7,117
|
7,985
|
24,043
|
98,624
|
| Net cash (used in) operating activities |
|
(2,421,086)
|
(1,306,657)
|
(7,710,862)
|
(6,992,313)
|
| Investing activities |
|
|
|
|
|
| Acquisition of equipment |
|
(7,844)
|
(15,600)
|
(21,567)
|
(170,790)
|
| Net cash (used in) investing activities |
|
(7,844)
|
(15,600)
|
(21,567)
|
(170,790)
|
| Financing activities |
|
|
|
|
|
| Cash acquired on acquisition |
|
|
|
0
|
266,635
|
| Proceeds from convertible loans |
|
2,934,298
|
500,000
|
7,111,375
|
2,000,000
|
| Proceeds on exercise of warrants |
|
0
|
1,125,038
|
1,125,038
|
40,195
|
| Proceeds from the exercise of options |
|
|
|
0
|
18,166
|
| Repayment of Promissory notes principal |
|
|
|
(200,000)
|
0
|
| Repayment of Demand notes principal |
|
(50,000)
|
0
|
(208,359)
|
0
|
| Repayment of Promissory notes interest |
|
|
|
(49,505)
|
0
|
| Repayment of Demand notes interest |
|
(2,975)
|
0
|
(79,259)
|
0
|
| Proceeds from short term loan |
|
|
|
400,000
|
0
|
| Repayment of short term loan |
|
|
|
(400,000)
|
0
|
| Repayment of short term loan interest |
|
|
|
(3,200)
|
0
|
| Net cash provided by financing activities |
|
2,881,323
|
1,625,038
|
7,696,090
|
2,324,996
|
| Net increase in cash and cash equivalents for the period |
|
452,393
|
302,781
|
(36,339)
|
(4,838,107)
|
| Cash and cash equivalents, beginning of period |
$ 5,381,757
|
507,311
|
543,650
|
543,650
|
5,381,757
|
| Cash and cash equivalents, end of period |
|
$ 959,704
|
$ 846,431
|
$ 507,311
|
$ 543,650
|
| Assets acquired and liabilities assumed at April 21, 2016: |
|
|
|
|
|
| Current assets, including cash of $266,635 |
478,843
|
|
|
|
|
| Equipment |
59,749
|
|
|
|
|
| Intangible assets |
5,580,704
|
|
|
|
|
| Goodwill |
22,308,275
|
|
|
|
|
| Accounts payable |
(241,299)
|
|
|
|
|
| Accrued liabilities |
(361,029)
|
|
|
|
|
| Customer deposits |
(86,487)
|
|
|
|
|
| Demand notes payable |
(324,894)
|
|
|
|
|
| Promissory Notes payable |
(217,808)
|
|
|
|
|
| Bionik advance |
(1,436,164)
|
|
|
|
|
| Non-cash consideration |
$ 25,759,890
|
|
|
|
|